Global EPA/DHA Omega-3 Market Size By Type (Capsule, Powder), By Application (Infant Formula, Fortified Foods and Beverages), By Region, And Segment Forecasts, 2023 to 2032

The Global EPA/DHA Omega-3 Market was valued at USD 3.1 billion in 2023 and is projected to reach USD 5.9 billion by 2031, expanding at a CAGR of 8.4% during the forecast period from 2023 to 2031. The market growth is driven by increasing awareness of the health benefits associated with EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), their rising incorporation in dietary supplements, functional foods, pharmaceuticals, and infant formula, and a growing elderly population worldwide. As consumer preference for preventive healthcare grows, the demand for high-quality omega-3 products is expected to continue accelerating globally.

Drivers:

1. Rising Health Awareness and Preventive Healthcare Trends:

Consumers are increasingly turning to nutritional supplements to maintain cardiovascular health, cognitive function, and overall wellness. EPA and DHA Omega-3 fatty acids are essential nutrients widely recognized for their anti-inflammatory, neuroprotective, and cardioprotective benefits, supporting strong market growth.

2. Growing Applications in Infant Nutrition and Pharmaceuticals:

The inclusion of DHA in infant formula is becoming standard in many countries due to its crucial role in brain development. Additionally, omega-3s are gaining recognition in pharmaceutical formulations targeting conditions such as depression, arthritis, and hypertriglyceridemia.

3. Expansion of Functional Foods and Beverages Market:

Omega-3-enriched products such as yogurts, milk, and beverages are gaining traction among health-conscious consumers, further diversifying market opportunities for food and beverage companies.

Restraints:

1. Supply Chain Challenges in Marine Sources:

EPA/DHA is primarily derived from fish oil, krill oil, and algal oil. Overfishing, environmental concerns, and regulatory scrutiny over marine biodiversity are creating uncertainties in the raw material supply chain.

2. Oxidative Stability and Taste Profile Issues:

Formulating food and supplements with omega-3s can be technically challenging due to their susceptibility to oxidation, which can compromise product quality, shelf-life, and palatability.

Opportunity:

1. Growth in Algal Oil-Based Omega-3 Products:

Plant-based and sustainable sources like algal oil are gaining popularity among vegetarians, vegans, and environmentally conscious consumers. The development of advanced algal fermentation technologies is expected to open new avenues for scalable, clean-label omega-3 production.

2. Regulatory Support and Clinical Research Backing:

Global regulatory bodies increasingly recognize the health benefits of omega-3s, leading to favorable labeling laws and health claims. Simultaneously, a robust pipeline of clinical studies continues to validate their efficacy, which will encourage wider adoption across medical and consumer health sectors.

Market by System Type Insights:

Based on source type, the Marine-Based Omega-3 Segment (Fish Oil, Krill Oil) held the dominant share in 2023, owing to its higher concentration of EPA and DHA. However, the Algal Oil Segment is poised for the fastest growth through 2031 due to increasing demand for plant-based and sustainable alternatives.

Market by End-use Insights:

By end use, the Dietary Supplements Segment led the market in 2023, contributing more than 45% of total revenue. The rising health-conscious population and aging demographic are key factors boosting supplement consumption. The Pharmaceutical Segment is also gaining traction, supported by ongoing clinical trials and increasing regulatory approvals for omega-3-based therapies.

Market by Regional Insights:

North America dominated the EPA/DHA Omega-3 market in 2023, driven by strong consumer awareness, established supplement consumption patterns, and a growing geriatric population. Asia-Pacific is expected to witness the highest CAGR during the forecast period, fueled by rising middle-class income, urbanization, and expanding nutraceutical and infant nutrition sectors in countries like China, India, and Japan.

Competitive Scenario:

Key players in the global EPA/DHA Omega-3 market include DSM Nutritional Products, BASF SE, KD Pharma Group, Orkla Health, GC Rieber Oils, Croda International Plc, Polaris Nutritional Lipids, Epax Norway AS, and BioProcess Algae. These companies are focusing on sustainable sourcing, R&D innovations in algae-based production, and strategic mergers to enhance their market footprint.

Scope of Work – Global EPA/DHA Omega-3 Market

Key Market Developments:

2023: DSM launched a new line of algal-based omega-3 ingredients targeting the vegan and vegetarian market, with enhanced bioavailability and oxidative stability.

2024: BASF partnered with a biotech firm to scale up fermentation-based EPA production, aiming for zero-waste and sustainable output.

2025: Epax announced a new molecular distillation technology that increases EPA/DHA purity for pharmaceutical-grade omega-3 applications.

FAQs:

1) What is the current market size of the Global EPA/DHA Omega-3 Market?

The market was valued at USD 3.1 billion in 2023.

2) What is the major growth driver of the Global EPA/DHA Omega-3 Market?

The key growth driver is the increasing awareness of the health benefits of omega-3 fatty acids, especially in cardiovascular and cognitive health.

3) Which is the largest region during the forecast period in the Global EPA/DHA Omega-3 Market?

North America dominated the market in 2023, while Asia-Pacific is expected to grow at the highest CAGR through 2031.

4) Which segment accounted for the largest market share in the Global EPA/DHA Omega-3 Market?

The Dietary Supplements segment held the largest share in 2023.

5) Who are the key market players in the Global EPA/DHA Omega-3 Market?

Key players include DSM Nutritional Products, BASF SE, KD Pharma Group, GC Rieber Oils, and Epax Norway AS.